Surgical vision,
reimagined.

A new imaging platform designed to give surgeons the visibility, freedom, and intelligence to operate at a higher level — across the full spectrum of minimally invasive surgery.

TRUE-3D™ Imaging Two-Handed Operation Single-Use

The Challenge

Surgeons have adapted to the limits of the endoscope. They shouldn't have to.

Minimally invasive procedures demand extraordinary precision — yet the endoscope, largely unchanged for decades, imposes fundamental constraints on every procedure. One hand occupied. One viewing angle. One portal consumed by the scope. These are structural limits on what’s surgically possible.

✶Single-handed operation

The endoscope occupies one hand at all times, preventing surgeons from working with the dexterity of both hands or requiring an assistant to hold the scope.

◎Limited visibility

The endoscope provides only a single viewing angle that doesn't always show the surgeon all relevant anatomy — critical information can remain out of view throughout the procedure.

⊕Constrained access

The endoscope occupies a crucial access port, reducing instrument flexibility and often requiring repositioning mid-procedure to achieve a different viewing angle.

◈No intelligent assistance

Current systems offer no AI layer to enhance intraoperative decision-making, guidance, or surgical awareness.

The Earendel Platform

One system.
Complete surgical freedom.

The Earendel System is designed to eliminate the constraints that define today’s minimally invasive OR. It is designed to enable TRUE-3D™ visualization and full two-handed surgical freedom. First indication: sports medicine. Built to expand across the full spectrum of minimally invasive surgery.

TRUE-3D™ Multi-Angle Imaging

Simultaneous multi-angle visualization — providing TRUE-3D™ views optimized for each step of the procedure.

Two-Handed Operation

Designed to free both hands — enabling a level of precision and surgical efficiency previously unavailable in MIS.

AI-Powered Views

Customizable, step-aware visualization guided by AI — designed to adapt to each phase of the procedure and support intraoperative decision-making.

Single-Use Design

Disposable by design. No sterilization or reprocessing overhead. Designed for rapid adoption across facilities.

Development Roadmap

Phase I · Now

Arthroscopy

Sports medicine — knee, shoulder, hip. 1.77M procedures annually in a $6.5B market.

Active Development

Phase II

Laparoscopy

Expanding the platform into abdominal and pelvic minimally invasive procedures.

Roadmap

Phase III

Neurosurgery

High-value neurological interventions requiring precision imaging and minimal access.

Roadmap

Beyond

Full MIS Platform

The Earendel Platform as the imaging and intelligence standard across minimally invasive specialties.

Vision

Validated by the Experts

Surgeons who used it. In their own words.

Reactions from practicing orthopedic surgeons following hands-on evaluation of the Earendel System.

“

Imagine arthroscopy with less complexity, more independence, and freedom from CapX. No need for an assistant, and no need for an expensive arthroscope.

Professor Jon J.P. Warner, MD

Founder, Boston Shoulder Institute

“

The most consequential ground breaking improvement in arthroscopic minimally invasive surgery in over a decade.

Professor Kenneth R. Zaslav, MD

Professor of Orthopedic Surgery, Zucker School of Medicine at Hofstra University · Director, Center for Regenerative Medicine, Lenox Hill Hospital

“

We are in an era of processes that are transforming our world and our daily practice. In many ways, Earendel is to arthroscopy what AI is to software development.

Professor Eran Maman, MD

Director of the Shoulder Surgery Unit, Tel Aviv Sourasky Medical Center, Israel

“

This is a truly innovative system pushing beyond the conventional limits of arthroscopy. Working with it opens a new depth of insight and precision. It is not merely a tool; it represents a true leap forward in surgical capability.

Dr. Hovav Tavor

Director of the Arthroscopy and Sports Injuries Unit, Kaplan Medical Center, Israel

Market Opportunity

A platform built for a multi-billion dollar market.

Minimally invasive surgery is one of the fastest-growing segments in healthcare — driven by aging populations, rising demand for faster recovery, and a global shift toward outpatient, cost-effective care. The Earendel Platform addresses a fundamental limitation that spans every MIS specialty.

The first addressed indication is arthroscopy — a $6.5B market with over 1.77 million procedures performed annually across knee, shoulder, hip, ankle, and wrist. The Earendel System is targeting FDA 510(k) clearance, with a regulatory strategy based on established single-use camera precedents, and a roadmap to expand into laparoscopy, neurosurgery, and adjacent MIS segments.

Platform opportunity

$20B+

Global minimally invasive surgery market

First indication — Arthroscopy

$6.5B

Arthroscopy market

1.77M

Procedures per year

7%+

Arthroscopy CAGR

510(k)

Target FDA pathway

Leadership

Built by people who know the OR.

Deep MedTech experience across image guidance, imaging, robotics and AI — combined with direct observation of surgical unmet needs.

Chen Levin

Co-Founder & CEO

20+ years in MedTech leadership. Founding CEO of three startups: RECMA Bio, XACT Robotics, and Biomagnesium Systems. Led companies from inception through commercialization. Key contributor to Israel’s biomed ecosystem growth. Member of the 8400 The Health Network. BA in International Relations, MBA in Finance from Hebrew University.

Guy Levy

Co-Founder & CBO

20+ years in MedTech sales, marketing, and clinical operations. Veteran of J&J and key commercial roles at OrthoSpace (acquired by Stryker), XACT Robotics, and BioProtect (acquired by Olympus). Founded Earendel Medical after identifying critical unmet needs through direct operating room experience. BSc in Paramedic Sciences, MHA in Healthcare Management from Ben Gurion University.

Moran Shochat

Co-Founder & CTO

25+ years in senior R&D leadership, including leading positions in HeraMED, XACT Robotics, and ActiViews (acquired by Stryker). Expert in medical navigation, image guidance, and AI integration for surgical applications. Led R&D for multiple FDA-cleared products including groundbreaking robotic and imaging systems. BSc Computer Science, Cum Laude, Technion Israel Institute of Technology.

Let's talk.

We welcome conversations with VCs, investors, strategic partners, and clinical collaborators with a shared interest in advancing minimally invasive surgery.

Guy Levy Co-Founder & CBO
Guy@Earendelmedical.com
+972.54.732.6723

Chen Levin Co-Founder & CEO
Chen@Earendelmedical.com
+972.52.229.5123

Send a Message

Surgical vision,reimagined.